Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin (Q44133705)

30 November 2017

title

Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin (English)

1 reference

Stanislava Stosic-Grujicic

30 November 2017

author

1

1 reference

Danijela Maksimović-Ivanić

30 November 2017

3

1 reference

30 November 2017

Ana Savic-Radojevic

2

1 reference

30 November 2017

Milos Markovic

4

1 reference

30 November 2017

Vladimir Bumbasirevic

5

1 reference

30 November 2017

Zorica Ramic

6

1 reference

30 November 2017

Marija Mostarica-Stojkovic

7

1 reference

30 November 2017

publication date

1 September 2002

1 reference

Journal of Neuroimmunology

30 November 2017

published in

1 reference

30 November 2017

volume

130

1 reference

30 November 2017

issue

1-2

1 reference

30 November 2017

page(s)

66-77

1 reference

Mycophenolate mofetil and its mechanisms of action

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

1 reference

7 January 2021

Differential effects of anti-rat CD11b monoclonal antibodies on granulocyte adhesiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Migratory Activity and Functional Changes of Green Fluorescent Effector Cells before and during Experimental Autoimmune Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Late complications of immune deviation therapy in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

The role of complement in the pathogenesis of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Ins and outs of LFA-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Immunotherapy of multiple sclerosis: where are we? Where should we go?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Synthesis and antiviral activity of certain thiazole C-nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Immunotherapy of multiple sclerosis: the end of the beginning

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Hematological toxicity associated with tiazofurin-influence on erythropoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Regulation of the signal transduction program by drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900210-2

7 January 2021

10.1016/S0165-5728(02)00210-2

Identifiers

DOI

1 reference

30 November 2017

1 reference